Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.

Saved in:
Bibliographic Details
Title: Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.
Authors: Alenazy FO; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia., Harbi MH; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia., Kavanagh DP; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Price J; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Brady P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, Sandwell and West Birmingham Hospitals National Health Service (NHS) Trust, Birmingham, United Kingdom., Hargreaves O; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Harrison P; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., Slater A; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Tiwari A; Department of Vascular Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Nicolson PLR; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Connolly DL; Department of Cardiology, Sandwell and West Birmingham Hospitals National Health Service (NHS) Trust, Birmingham, United Kingdom., Kirchhof P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, University Heart and Vascular Center (UKE) Hamburg, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Germany., Kalia N; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Jandrot-Perrus M; UMR_S1148, INSERM, Paris, France., Mangin PH; UMR_S1255, INSERM, Etablissement Francais du Sang-Alsace, Strasbourg, France., Watson SP; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Centre of Membrane Proteins and Receptors (COMPARE), The Universities of Birmingham and Nottingham, The Midlands, United Kingdom., Thomas MR; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, Sandwell and West Birmingham Hospitals National Health Service (NHS) Trust, Birmingham, United Kingdom; Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. Electronic address: markthomas@doctors.org.uk.
Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Nov; Vol. 21 (11), pp. 3236-3251. Date of Electronic Publication: 2023 Aug 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7836
DOI:10.1016/j.jtha.2023.07.018